Study of the Transmission-Blocking Vaccine Pfs230D1-EPA/Matrix-M Against Malaria in Adults in Mali
Clinical trial NCT05135273 · COMPLETED
Trial details
- NCT number
- NCT05135273
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-22
- Primary completion
- 2023-02-17
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.